Biomarkers in Prediction of AMI
Recruiting
N/A
Interventional Study
Acute Mesenteric Ischemia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 250 (estimated)
- Sponsor
- University of Tartu · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18 years or older
* Initial decision in favour of further diagnostics of mesenteric ischaemia
Exclusion Criteria:
* Age \<18 years
* Consent declined by patient or next of kin (delayed consent)
* Chronic mesenteric ischaemia without an acute event
* Immediate decision fo…
Contacts